Toceranib(SU 11654; PHA 291639)是激酶抑制剂,有抗肿瘤和抗血管生成活性,能抑制KIT,VEGFR2和PDGFRβ。 Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Toceranib
CAS number:356068-94-5 molecular formula:C22H25FN4O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Toceranib | BDBM4818 | AS-31877 | EINECS 206-730-8 | toceranibum | 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide | UNII-621BVT9M36 | MFCD16038046 | SU 11654 | 4720B | 59L7 | ||
| CAS number | 356068-94-5 | molecular formula | C22H25FN4O2 |
| molecular weight | 396.46 g/mol | Exact mass | ≥98% |
| PSA | 77.200 Ų | logp | 2.400 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





